We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ALBIO market cap is 33.84M. The company's latest EPS is EUR -3.4334 and P/E is -0.91.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 36.13M | 168.64M | 382.53M | 206.53M | 109.26M |
| Operating Income | 1.6M | 51.75M | 144.36M | 38.88M | -37.41M |
| Net Income | 1.1M | 31.37M | 104M | 15.61M | -36.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 47M | 126.07M | 268.94M | 260.34M | 241.73M |
| Total Liabilities | 16.48M | 59.79M | 101.14M | 93.44M | 117.41M |
| Total Equity | 30.52M | 66.29M | 167.81M | 166.9M | 124.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | N/A | 31.64M | 109.83M | 4.95M | -9.65M |
| Investing | N/A | -7.93M | -28.96M | -39.08M | -54.81M |
| Financing | N/A | 10.62M | 14.4M | -10.81M | 5.17M |
| Market Cap | 33.84M |
| Price to Earnings Ratio | -0.91 |
| Price to Sales Ratio | 0.31 |
| Price to Cash Ratio | 1.68 |
| Price to Book Ratio | 0.27 |
| Dividend Yield | - |
| Shares Outstanding | 10.76M |
| Average Volume (1 week) | 7.19k |
| Average Volume (1 Month) | 9.02k |
| 52 Week Change | -67.58% |
| 52 Week High | 11.00 |
| 52 Week Low | 2.95 |
| Spread (Intraday) | 0.06 (1.88%) |
| Company Name | Biosynex |
| Address |
22 boulevard sebastien brant illkirch-graffenstaden, bas-rhin 67400 |
| Website | https://www.biosynex.com |
| Industry | offices of medical doctors (8011) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
